Agios Pharmaceuticals, Inc. (AGIO)
Market Closed
26 Oct, 08:00 PM
$
36. 85
-0.15
-0.4054%
$
1.87B Market Cap
- P/E Ratio
- Div Yield
838,530 Volume
- Eps
$ 37
Previous Close 
Want to track AGIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study
Agios Pharmaceuticals said on Monday its experimental treatment for an inherited blood disorder met the main goal in a late-stage study.
Reuters | 2 years ago
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
Agios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential net sales of a brain cancer drug that was sold to Servier in 2021.
Zacks | 2 years ago
How Much Upside is Left in Agios Pharmaceuticals (AGIO)? Wall Street Analysts Think 26.43%
The mean of analysts' price targets for Agios Pharmaceuticals (AGIO) points to a 26.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
